Skip to main navigation Skip to search Skip to main content

(Lys9)GLP-1 possesses DPP IV resistance and cellular and metabolic actions similar to those of established antagonists GLP-1(9-36)amide and exendin(9-39).

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)P10
JournalIrish journal of medical science
Volume172
Issue numberS1
Publication statusPublished - 2003

Cite this